Filing Flows › Elevance Health (ELV) › Free cash flow
Elevance Health (ELV) free cash flow by quarter
Elevance Health's free cash flow was $1.0B in Q3 2026 (third quarter 2026), -38% from Q2 2026. Over the last 6 quarters it ranged from $775M (Q3 2025) to $4.1B (Q1 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.0B | -38% | +29% |
| Q2 2026 | $1.6B | -60% | -9% |
| Q1 2026 | $4.1B | +429% | +399% |
| Q3 2025 | $775M | -57% | — |
| Q2 2025 | $1.8B | +118% | — |
| Q1 2025 | $821M | — | — |
Q3 2026 at a glance
Elevance Health, Q3 2026: revenue $51.4B (+1% year over year), operating margin 2.5%, net earnings $1.3B, operating cash flow $1.3B. The chart follows the revenue to costs, profit and cash.
Questions
What is Elevance Health's free cash flow?
Elevance Health's free cash flow was $1.0B in Q3 2026 (third quarter 2026), -38% from Q2 2026.
How has Elevance Health's free cash flow changed?
Over the last 6 quarters it ranged from $775M (Q3 2025) to $4.1B (Q1 2026).